Literature DB >> 20839776

Bioisosteric replacement leading to biologically active [2.2]paracyclophanes with altered binding profiles for aminergic G-protein-coupled receptors.

Marika Skultety1, Harald Hübner, Stefan Löber, Peter Gmeiner.   

Abstract

Exploring the chemical diversity space of GPCR ligands, we recently discovered [2.2]paracyclophanes as valuable atypical bioisosteres for secondary affinity and selectivity generating moieties. To find out if such an exchange also works for structural moieties that simulate the endogenous neurotransmitter, π1 or π2 or both systems π1 and π2 of three representative privileged structures of types 1, 2, and 3 were replaced by a [2.2]paracyclophane unit. Contributions of the respective functionalities to the binding affinities of a panel of relevant monoaminergic GPCRs were systematically examined. The study led to the paracyclophanylpiperazine 3a displaying excellent D(3) affinity (K(i) = 1.6 nM) and a strongly attenuated binding to D(4), 5-HT(1) and α(1). Whereas functional experiments showed neutral D(3) antagonist properties, mutagenesis studies indicated a binding mode that is similar to its lead compounds of type 3.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20839776     DOI: 10.1021/jm100899z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Bioisosteric matrices for ligands of serotonin receptors.

Authors:  Dawid Warszycki; Stefan Mordalski; Jakub Staroń; Andrzej J Bojarski
Journal:  ChemMedChem       Date:  2015-03-13       Impact factor: 3.466

2.  A small molecule screen identifies novel inhibitors of mechanosensory nematocyst discharge in Hydra.

Authors:  Diana Hofmann; Niharika Garg; Simone Grässle; Sylvia Vanderheiden; Bruno Gideon Bergheim; Stefan Bräse; Nicole Jung; Suat Özbek
Journal:  Sci Rep       Date:  2021-10-18       Impact factor: 4.379

3.  The concise synthesis and resolution of planar chiral [2.2]paracyclophane oxazolines by C-H activation.

Authors:  Shashank Tewari; Maulik N Mungalpara; Suraj Patel; Gareth J Rowlands
Journal:  RSC Adv       Date:  2022-03-17       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.